Sensible Biotechnologies Raises $4.2Mn In A Pre-Seed Financing Round To Revolutionize Mrna Manufacturing

Apr 06, 2023•over 2 years ago

Amount Raised

$4.2 Million

Round Type

pre-seed

OxfordBiotechnology

Investors

Dla PiperJason C. FosterFlorian SchusterZakaRecode Health VenturesCivilization VenturesAmino CollectiveY CombinatorBlue Yard Capital

Description

Sensible Biotechnologies, Inc., an mRNA platform company, has announced a $4.2mn pre-seed round to accelerate the development of its cell-based platform for cost-efficient manufacturing of high-quality mRNA. The company's technology aims to overcome the limitations of current mRNA manufacturing processes, ensuring scalable and cost-effective production of mRNA with high quality.

Company Information

Company

Sensible Biotechnologies

Location

2093 Philadelphia Pike #3008

Oxford, Mississippi, United States

About

Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA. Sensible's platform eliminates the major bottlenecks in the mRNA production process in an effort to unlock the full potential of mRNA technology for the next generation of therapeutics and vaccines. Sensible aims to become an integral part of the global biomanufacturing infrastructure and biosecurity framework. Sensible Biotechnologies is based in Oxford, United Kingdom, and in Bratislava, Slovakia. For further information, visit www.sensible.bio, and follow us on Twitter @sensible_bio.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns